Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EF-hand calcium-binding domain-containing protein 14 (EFCAB14) is a human protein characterized by the presence of EF-hand motifs, which are helix–loop–helix structures that bind calcium ions with high specificity[1][2][3]. EFCAB14 is involved in calcium signaling pathways inside cells and likely plays a regulatory role in various cellular processes dependent on calcium flux, such as those related to neuronal and cardiovascular function[1][3]. While antibodies and detection kits for EFCAB14 exist for research use, there are currently no drugs or therapeutic mechanisms known to target this specific molecule, and it is not currently classified as a therapeutic target such as a receptor, enzyme, transporter, or transcription factor[1][3]. Its gene annotations include calcium ion binding activity and predicted membrane localization[3]. There is no evidence of EFCAB14 being established as a biomarker or as having safety concerns related to clinical targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EF-hand calcium-binding domain-containing protein 14 (EFCAB14).